<DOC>
	<DOCNO>NCT01856543</DOCNO>
	<brief_summary>The purpose study find effect mometasone furoate different Eucerin decreasing severity redness skin irradiation , prevent skin peeling , reduce amount irritation patient report treatment .</brief_summary>
	<brief_title>Mometasone Furoate 0.1 % Versus Eucerin Moderate Severe Skin Toxicities Breast Cancer Patients Receiving Postmastectomy Radiation</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Age â‰¥18 year Stage 14 invasive breast cancer histologically confirm MSKCC Status post mastectomy axillary exploration ( sentinel node biopsy and/or axillary lymph node dissection ) receive PMRT ECOG Performance Status 0 1 Male Patients clinical evidence gross disease Patients pregnant breastfeed Prior radiation therapy ipsilateral chest wall thorax Patients require chest wall boost Concurrent chemotherapy ( biologic agent allow ) Psychiatric illness would prevent patient give informed consent Inability unwillingness comply skin care instruction followup Allergy either Eucerin MF Residual grade &gt; 1 skin toxicity , cellulitis , incompletely heal wound ( ) intend site study drug application time start RT Medical condition uncontrolled infection ( include HIV ) , uncontrolled diabetes mellitus , connective tissue disease ( lupus , systemic sclerosis , collagen vascular disease ) Treatment palliative preoperative radiation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Status post mastectomy</keyword>
	<keyword>plan receive PMRT</keyword>
	<keyword>Topical</keyword>
	<keyword>steroid cream</keyword>
	<keyword>emollient skin care</keyword>
	<keyword>Eucerin</keyword>
	<keyword>Mometasone Furoate 0.1 %</keyword>
</DOC>